ASF devastates Mizoram, guv urges action
In a crucial meeting at the Raj Bhavan, the governor highlighted the animal husbandry & veterinary department's limited capacity to combat the crisis alone, urging for enhanced inter-departmental collaboration and public involvement.
The ASF outbreak, first detected in Lungsen village in March 2021, has resulted in the death of 69,411 pigs and the culling of 52,194 more, affecting 11,382 households and causing financial losses estimated at Rs 982.16 crore. Despite disbursing Rs 1,451.915 lakh in compensation and additional funds from the state disaster management & rehabilitation department, ASF remains endemic in Mizoram.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
20 minutes ago
- News18
Hyderabad To Vijayawada In Just 2 Hours? Telangana's New Greenfield Highway Work On Track
Last Updated: This Rs 650-crore project is aimed at reducing heavy traffic and will link key areas like Hayathnagar via the Outer Ring Road (ORR). The Telangana government is planning a brand-new greenfield highway that will cut down travel time between Hyderabad and Vijayawada to just two hours. As per The New Indian Express, State Roads & Buildings Minister Komatireddy Venkat Reddy shared this exciting update during an inspection in Vanasthalipuram. How Will LB Nagar Benefit? One of the major projects in focus is a six-kilometre elevated corridor from LB Nagar to Pedda Amberpet. This Rs 650 crore project aims to ease traffic in this busy stretch. It will link directly to the Outer Ring Road (ORR), providing smoother access to Hayathnagar and beyond. The minister also highlighted that Rs 541 crore was already secured for road work between LB Nagar and Malkapur during his MP tenure, and he now aims to finish all pending works without delay. To make roads safer, the government has identified 17 accident-prone black spots that will be fixed on priority. What's Next for Metro and Rail Projects? The minister will soon meet Union Minister Nitin Gadkari to fast-track approvals for Metro Phase-II and the Regional Ring Railway. What About Healthcare? Telangana's healthcare scene is getting a boost too. The super-specialty TIMS Hospital in Sanathnagar will open this September. More such hospitals are coming up to provide corporate-level care to citizens. view comments First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Business Standard
35 minutes ago
- Business Standard
Sanofi Consumer Healthcare spurts after Q2 results
Sanofi Consumer Healthcare India surged 12.56% to Rs 5385 after the company announced strong financial results for the second quarter of 2025. The company reported a 28% year-on-year rise in revenue to Rs 220.9 crore in Q2 2025, powered by export operations and successful product launches. On a sequential basis, the companys revenue rose 27.5% from Rs 172.6 crore in Q1 2025. Profit after tax (PAT) for the quarter stood at Rs 60.7 crore, marking a 21% increase over Q1FY25 and a 109% surge from Rs 29 crore in Q2 2024. Profit before tax (PBT) came in at Rs 78.9 crore, up 102.83% YoY and 18.11% QoQ. While result is impressive, the company noted that financials are not strictly comparable due to the demerger and voluntary recall of certain variants of key brands. Net cash flow from operations during the half year ended 30 June 2025 stood at Rs 17.9 crore, steeply down from Rs 231.50 crore in the same period last year. Himanshu Bakshi, managing director, Sanofi Consumer Healthcare India, said: "Our commitment to delivering high-quality, science-backed products continues to anchor our growth strategy-driven by a focused portfolio, research-led innovation, and an agile organization. This quarter reflects the outcomes of that focused approach, with successful relaunch of two previously recalled products and introduction of a new product. We also commenced export operations allowing us to extend our efforts towards international markets. As we look ahead, we remain steadfast in our purpose to make self-care simpler, more accessible and effective for consumers." During the half year, the company launched Allegra D, a unique proposition in the Allergy segment, also relaunched Depura 60k and Combiflam Suspension which were recalled voluntarily last year. Other legacy brands such as Avil, and Depura continue to uphold strong consumer trust and drive long-term relevance in their respective categories. Sanofi Consumer Healthcare India officially demerged from Sanofi India on 1 June 2024 and now operates as an independent entity focused solely on the consumer healthcare segment. Its key product categories include allergy care, digestive wellness, pain relief, multivitamins, and herbal/traditional supplements, with flagship brands such as Allegra, DePURA, Avil, and Combiflam anchoring its portfolio.
News18
2 hours ago
- News18
Why Haryana's Public Health System Is Crumbling With Pending Dues From Ayushman Bharat
Haryana's public healthcare system is collapsing under the weight of over-promising, financial mismanagement, and a lack of strategy In an attempt to manage shrinking healthcare funds, the Haryana government in June dropped several high-demand treatment packages—including cataract, hysterectomy, laparoscopic cholecystectomy, gastroenteritis, and Chronic Obstructive Pulmonary Disease (COPD)—from both the Ayushman Bharat and Chirayu Yojana health insurance schemes for private hospitals. While that decision is still rippling across hospitals and patients alike, another storm is brewing: over 650 private hospitals are preparing to halt Ayushman Bharat services starting August 7, citing unpaid dues of over Rs 500 crore. But this isn't just a payment delay issue. Haryana's public healthcare system is collapsing under the weight of over-promising, financial mismanagement, and a lack of strategy. How Did We Get Here? Haryana's health insurance net has grown rapidly in recent years. Under the Centre's Ayushman Bharat–Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), the state covered about 70–80 lakh beneficiaries. But in a bid to widen the safety net, the state launched Chirayu Yojana, expanding total coverage to a staggering 1.8 crore people—over 70 per cent of the state's 2.5 crore population. This expansion was not backed by a scalable financial roadmap. 'In trying to serve too many, the government is now unable to serve anyone properly," said Dr Ajay Mahajan, former president of the Indian Medical Association (IMA), Haryana. 'They over-promised but didn't have the budget to sustain it." Mahajan was IMA Haryana's president when the dialogues with the state government started for expanding the funding. 'In 2023–24, the total budget for these health schemes was Rs 1,300 crore, which increased to Rs 1,800 crore in 2024–25. During multiple meetings with the chief minister and his office, private hospital representatives were assured that the allocation would rise to Rs 2,000–2,500 crore. Instead, it was slashed to Rs 700 crore—causing a severe funding crisis." 'That entire amount of Rs 175 crore, from the first quarterly release, officials confirm, has already been used to clear old unpaid dues from previous years, leaving this year's reimbursements pending. Rs 175 crore has been used to clear old dues. There is no money left to clear the latest dues." Why Top-Selling Packages Were Removed In a notice titled 'Regarding Reservation of Medical & Surgical Packages for Government Hospitals", issued on 23 June 2025, seen by News18, the Ayushman Bharat Haryana announced that five high-demand procedures would now be reserved exclusively for public (government) hospitals. They labelled the move as part of efforts 'to streamline package utilization under Ayushman Bharat HHPA and to avoid over-utilization by private empanelled hospitals." The five procedures—Phacoemulsification with foldable hydrophobic acrylic IOL, Abdominal Hysterectomy, Acute Exacerbation of COPD, Acute Gastroenteritis with Severe Dehydration, and Laparoscopic Cholecystectomy (Without CBD Exploration)—are in addition to 114 packages already reserved for government facilities. The notice further directed officials to 'update the TMS portal accordingly, so that booking of these packages is restricted to Government Hospitals only," adding that the step will 'enhance service delivery at public health institutions and ensure judicious use of scheme funds." However, IMA Haryana and other private hospitals believe that the move is to cut budget under the scheme as these packages, especially cataract surgery, had very high demand. 'The more the packages sold in private hospitals, higher the bills for reimbursement become pending," Mahajan said. About 700 private hospitals in Haryana are empanelled under the scheme—many of them mid-sized nursing homes and speciality centres that serve 90 per cent of Ayushman patients. The public sector, though nearly equal in number of hospitals, attracts only 10 per cent of patients. 'Most tertiary care and super-speciality beds—about 80–85 per cent—are with private hospitals," said Dr Girdhar Gyani, director general of the Association of Healthcare Providers India (AHPI). 'These hospitals cannot survive long payment delays. The government's intent may be genuine, but without a strategy and cash flow, the system is breaking down." Hospitals say they are facing operational stress, rising costs, and zero liquidity. Payments have been delayed by up to five months in some cases. Arbitrary deductions and administrative apathy have only added to the strain. 'The only solution is to charge 1 per cent interest as a penalty for the amount due. This penalty was part of the original Ayushman Bharat scheme when launched in 2018. However, states have removed that clause due to their own convenience." Quiet Cuts, Loud Consequences To deal with the mounting costs, the government has begun cutting down packages. Mahajan confirmed to News18 that several high-volume, commonly claimed procedures were quietly removed from the Ayushman and Chirayu lists months ago. These include cataract surgeries, hysterectomies, gallbladder removals, and even procedures related to gastrointestinal and COPD conditions. 'Cataract was the top-selling procedure, and they have removed that as well." 'These five were core treatments, especially for the poor," he said. 'Removing them doesn't just balance the books—it leaves lakhs of people with no option but to pay out of pocket or skip care altogether." The cost of running both schemes simultaneously, Mahajan said, has created an unsustainable financial burden, with the state now facing the consequences of overpromising. Last-Ditch Talks, With Conditions top videos View all Talks between the government and hospital associations are ongoing. A meeting scheduled on Monday was postponed, but fresh dates have been proposed. Hospital leaders say they're still open to negotiation. 'We were planning to meet the state government officials today, but the meeting was cancelled," Gyani said, adding, 'If we get a firm assurance and timelines, we might give them a week's extension. But if the funds are not released soon, we will have no choice but to stop services. We simply don't have the money to treat patients under Ayushman." About the Author Himani Chandna Himani Chandna, Associate Editor at CNN News18, specialises in healthcare and pharmaceuticals. With firsthand insights into India's COVID-19 battle, she brings a seasoned perspective. She is particularly More Get breaking news, in-depth analysis, and expert perspectives on everything from politics to crime and society. Stay informed with the latest India news only on News18. Download the News18 App to stay updated! tags : Ayushman Bharat cataract gall bladder haryana news18 specials view comments Location : New Delhi, India, India First Published: August 05, 2025, 12:20 IST News india Why Haryana's Public Health System Is Crumbling With Pending Dues From Ayushman Bharat Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
